Cargando…

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?

OBJECTIVE: The use of electroconvulsive therapy (ECT) in the treatment of bipolar disorder (BD) remains poorly described. Based on data from Danish registries with complete nationwide coverage, this study of patients with incident BD aimed to describe when, how, and for whom ECT is used in the conte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salagre, Estela, Rohde, Christopher, Vieta, Eduard, Østergaard, Søren D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087321/ https://www.ncbi.nlm.nih.gov/pubmed/36064283 http://dx.doi.org/10.1111/bdi.13254

Ejemplares similares

The effectiveness of involuntary electroconvulsive therapy (ECT): A population-based study
por: Salagre, E., et al.
Publicado: (2021)

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Inam, Mehmet Enes, et al.
Publicado: (2023)

Risk Calculators in Bipolar Disorder: A Systematic Review
por: Silva Ribeiro, Joana, et al.
Publicado: (2020)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Freeze-all, for whom, when, and how
por: Celada, Paula, et al.
Publicado: (2020)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

Efficacy of Electroconvulsive Therapy in Bipolar Disorder with Mixed Features
por: Palma, Miguel, et al.
Publicado: (2016)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

Suicide following treatment with electroconvulsive therapy: A nationwide study of risk factors among 11,780 patients
por: Østergaard, S. D., et al.
Publicado: (2023)

Electroconvulsive therapy for Patients with Intellectual Disability. When and how?
por: Azevedo, F., et al.
Publicado: (2022)

Non-invasive ventilation in the ED: Whom, When, How?
por: Göksu, Erkan, et al.
Publicado: (2018)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)

Efficacy of Electroconvulsive Therapy for Comorbid Frontotemporal Dementia with Bipolar Disorder
por: Paul, Sean, et al.
Publicado: (2013)

Bipolar disorder, pregnancy, COVID-19: Electroconvulsive therapy is needed!
por: Guerra, M.F. Tascon, et al.
Publicado: (2021)

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How
por: Pavanello, Francesca, et al.
Publicado: (2016)

The kynurenine pathway in schizophrenia, bipolar disorder, and major depressive disorder: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Salagre, E., et al.
Publicado: (2023)

Catatonia Development in a Patient with Bipolar Disorder Following Electroconvulsive Therapy: A Case Report
por: Mashayekhi, Azadeh, et al.
Publicado: (2019)

A Review of Asenapine in the Treatment of Bipolar Disorder
por: Vieta, Eduard, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020)

Pediatric Percutaneous Endoscopic Gastrostomy in Korea - When? By Whom? How?
por: Lee, Yoon
Publicado: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
por: Weseler, Antje R., et al.
Publicado: (2023)

Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?
por: Carrero, Juan J, et al.
Publicado: (2022)

Clinical profile and outcome of bipolar disorder patients receiving electroconvulsive therapy
por: Bouali, W., et al.
Publicado: (2021)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

When Obsessive Compulsive Disorder Responds Only to Electroconvulsive Therapy: A Rare Case for Maintenance Electroconvulsive Therapy?
por: Agrawal, Adesh, et al.
Publicado: (2018)

Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
por: Sullivan, Zachary P., et al.
Publicado: (2022)

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2009)

Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors
por: Popiolek, K., et al.
Publicado: (2019)

Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2010)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement
por: Abbott, Christopher C., et al.
Publicado: (2019)

Predictors for Extending Hospitalization Stay in Electroconvulsive Therapy Recipients With Bipolar Disorder, Manic Episodes
por: Bodicherla, Krishna Priya, et al.
Publicado: (2020)

Salvage radiotherapy with or without hormone therapy: for whom and when?
por: Carrie, Christian
Publicado: (2017)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_506de84qi14s7lv51bkl9e3um6